Home/Filings/4/0001062993-22-002992
4//SEC Filing

Welzenbach Mark Joseph 4

Accession 0001062993-22-002992

CIK 0000944695other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 10:36 AM ET

Size

13.5 KB

Accession

0001062993-22-002992

Insider Transaction Report

Form 4
Period: 2022-02-04
Welzenbach Mark Joseph
Senior Vice President
Transactions
  • Exercise/Conversion

    Common Stock Option (right to buy)

    2022-02-0410,3770 total
    Exercise: $104.11Exp: 2028-02-27Common Stock (10,377 underlying)
  • Exercise/Conversion

    Common Stock

    2022-02-04$104.11/sh+10,377$1,080,34930,419.077 total
  • Sale

    Common Stock

    2022-02-04$138.50/sh10,377$1,437,21520,042.077 total
  • Exercise/Conversion

    Common Stock

    2022-02-04$117.22/sh+4,686$549,29324,728.077 total
  • Sale

    Common Stock

    2022-02-04$140.42/sh4,686$658,03020,042.077 total
  • Exercise/Conversion

    Common Stock Option (right to buy)

    2022-02-044,6862,343 total
    Exercise: $117.22Exp: 2029-03-05Common Stock (4,686 underlying)
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $140.11 to $140.55. The Reporting Person undertakes to provide The Hanover Insurance Group, Inc. ("THG"), any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F2]The option, representing the right to purchase a total of 15,566 shares, vested 1/3 on each of 2/27/19, 2/27/20 and 2/27/21.
  • [F3]The option, representing the right to purchase a total of 7,029 shares, vested 1/3 on each of 3/05/20 and 3/05/21 and the remaining 1/3 shall vest on 3/05/22.

Issuer

HANOVER INSURANCE GROUP, INC.

CIK 0000944695

Entity typeother

Related Parties

1
  • filerCIK 0001576903

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 10:36 AM ET
Size
13.5 KB